Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: A prospective trial

Eye (Basingstoke)

Volumn 27, Issue 4, 2013, Pages 538-544

  Rootman, D B ^a   Gill, H S ^a   Margolin, E A ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

angiogenesis inhibitors; bevacizumab; eye diseases; optic nerve diseases; optic neuropathy, ischemic; vascular diseases

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARTMENT SYNDROME; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA ABRASION; CORNEA DISEASE; DIABETIC RETINOPATHY; EARLY INTERVENTION; ENDOPHTHALMITIS; EYE EDEMA; EYE EXAMINATION; FEMALE; HUMAN; INTRAOCULAR PRESSURE; ISCHEMIC OPTIC NEUROPATHY; MALE; OPTIC NERVE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RETINAL NERVE FIBER LAYER THICKNESS; SCORING SYSTEM; SIDE EFFECT; THICKNESS; VISUAL FIELD;

EID: 84876132686     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2012.296     Document Type: Article

References (30)

1. Botelho PJ, Johnson LN, Arnold AC. The effect of aspirin on the visual outcome of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1996; 121: 450-451.
2. Dickersin K, Everett D, Feldon S, Hooper F, Kaufman D, Kelman S et al. Optic-nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (naion) is not effective and may be harmful. JAMA 1995; 273: 625-632.
3. Kaufman D, Dickersin K, Kelman S, Langenberg P, Newman N, Wilson PD. Ischemic optic neuropathy decompression trial: twenty-four-month update. Arch Ophthalmol 2000; 118: 793-798.
4. Modarres M, Sanjari MS, Falavarjani KG. Vitrectomy and release of presumed epipapillary vitreous traction for treatment of nonarteritic anterior ischemic optic neuropathy associated with partial posterior vitreous detachment. Ophthalmology 2007; 114: 340-344.
5. Soheilian M, Koochek A, Yazdani S, Peyman GA. Transvitreal optic neurotomy for nonarteritic anterior ischemic optic neuropathy. Retin-J Retin Vitr Dis 2003; 23: 692-697.
6. Wilhelm B, Ludtke H, Wilhelm H, Grp BS. Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial. Graefes Arch Clin Exp Ophthalmol 2006; 244: 551-558.
7. Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuro-Ophthal 2003; 23: 157-163.
8. Hayreh SS, Zimmerman MB. Optic disc edema in non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1107-1121.
9. Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1029-1046.
10. Jonas JB, Spandau UH, Harder B, Sauder G. Intravitreal triamcinolone acetonide for treatment of acute nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 2007; 245: 749-750.
11. Kaderli B, Avci R, Yucel A, Guler K, Gelisken O. Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 2007; 27: 164-168.
12. Yaman A, Selver OB, Saatci AO, Soylev MF. Intravitreal triamcinolone acetonide injection for acute non-arteritic anterior ischaemic optic neuropathy. Clin Exp Optom 2008; 91: 561-564.
13. Sohn BJ, Chun BY, Kwon JY. The effect of an intravitreal triamcinolone acetonide injection for acute nonarteritic anterior ischemic optic neuropathy. Korean J Ophthalmol 2009; 23: 59-61.
14. Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010; 117: 1064-1077.e35.
15. Wu L, Arevalo JF, Berrocal MH, Maia M, Roca JA, Morales-Cantón V et al. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months. Retin-J Retin Vitr Dis 2010; 30: 1002-1011.
16. Bennett JL, Thomas S, Olson JL, Mandava N. Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab. J Neuroophthalmol 2007; 27: 238-240.
17. Kelman S, Elman M, Mandava N, Bennett J. Intravitreal bevacizumab for nonarteritic anterior ischemic optic neuropathy: a pilot study. In: Proceeds from the Meeting of the North American Neuro-Ophthalmological Society Lake Tahoe, NV, 2009.
18. Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology 2008; 115: 298-305.e2.
19. Boghen DR, Glaser JS. Ischemic optic neuropathy-clinical profile and natural-history. Brain 1975; 98: 689-708.
20. Sawle GV, James CB, Russell RWR. The natural-history of nonarteritic anterior ischemic optic neuropathy. J Neurol Neurosurg Psychiatry 1990; 53: 830-833.
21. Prescott CR, Sklar CA, Lesser RL, Adelman RA. Is intravitreal bevacizumab an effective treatment option for nonarteritic anterior ischemic optic neuropathy? J Neuroophthalmol 2012; 32: 51-53
22. Newman NJ, Scherer R, Langenberg P, Kelman S, Feldon S, Kaufman D et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002; 134: 317-328.
23. Hayreh SS, Podhajsky PA, Zimmerman B. Ipsilateral recurrence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 2001; 132: 734-742.
24. Pepple KL, Bhatti MT, Foroozan R. Not Again! Surv Ophthalmol 2011; 56: 86-93.
25. Ganssauge M, Wilhelm H, Bartz-Schmidt KU, Aisenbrey S. Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (AvastinA (R)) for treatment of angoid streaks in pseudoxanthoma elasticum. Graefes Arch Clin Exp Ophthalmol 2009; 247: 1707-1710.
26. Huang JY, Ozaki H, Hayashi H, Uchio E. Anterior ischemic optic neuropathy following intravitreal bevacizumab. Jpn J Ophthalmol 2010; 54: 252-254.
27. Hosseini H, Razeghinejad MR. Anterior ischemic optic neuropathy after intravitreal injection of bevacizumab. J Neuroophthalmol 2009; 29: 160-161.
28. Falkenstein IA, Cheng L, Freeman WR. Changes of intraocular pressure after intravitreal injection of bevacizumab (avastin). Retin-J Retin Vitr Dis 2007; 27: 1044-1047.
29. Hollands H, Wong J, Bruen R, Campbell RJ, Sharma S, Gale J. Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol 2007; 42: 807-811.
30. Hayreh SS, Zimmerman MB. Incipient nonarteritic anterior ischemic optic neuroplathy. Ophthalmology 2007; 114: 1763-1772.